DOES TESTING FOR CIRCULATING AUTOANTIBODIES AGAINST DISEASE-RELEVANT CITRULLINATED ANTIGENS ADD VALUE TO THE CCP2 ASSAY IN DIAGNOSING RA AMONG EARLY UNDIFFERENTIATED ARTHRITIS PATIENTS?

समान संसाधन

• DOES TESTING FOR CIRCULATING AUTOANTIBODIES AGAINST DISEASE-RELEVANT CITRULLINATED ANTIGENS ADD VALUE TO THE CCP2 ASSAY IN DIAGNOSING RA AMONG EARLY UNDIFFERENTIATED ARTHRITIS PATIENTS?
  द्वारा: Pratt, A, और अन्य
  प्रकाशित: (2011)
• Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort.
  द्वारा: Pratt, A, और अन्य
  प्रकाशित: (2011)
• Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort
  द्वारा: Pratt, A, और अन्य
  प्रकाशित: (2011)
• A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritis
  द्वारा: Heather A. Nelson, और अन्य
  प्रकाशित: (2024-08-01)
• Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis Reply
  द्वारा: Lundberg, K, और अन्य
  प्रकाशित: (2010)